The AI Pioneer Developing New Kinds of Medici...

Hello What's Your Problem? listeners! We'd like to introduce you to a show we think you might like. Here We Go Again is a brand-new podcast, where actor, author, comedian, and former White House staffer Kal Penn takes today’s trends and headlines and asks: Why does history keep r ...  Show more

Michael Hufford is the co-founder and CEO of LyGenesis, a company working on a new treatment for end stage liver disease. Michael’s problem is this: How do grow a new liver inside the body of a sick patient? In this episode, Michael explains: The liver's unique power of regenerat ...  Show more

Today’s AI Daily Brief asks when artificial intelligence will begin making real scientific discoveries. We look at Periodic Labs, which just raised more than $300 million to build AI scientists and autonomous labs for physics and chemistry, and Thinking Machines, which is creatin ...  Show more

In this episode, we take a closer look at Elon Musk's AI research company, Grok, and its latest development: the addition of an image generation capability called FLUX to its AI model. We discuss the potential implications of this advancement, which combines text and image genera ...  Show more

Tom Koulopoulos discusses his book The Bottomless Cloud and how AI and the Cloud are radically transforming the way we do business. Tom compares today's digital revolution to the in ...

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more